α2-MG

Upregulation of salivary α2 macroglobulin in patients with type 2 diabetes mellitus

J. K. Feng, Lu, Y. F., Li, J., Qi, Y. H., Yi, M. L., and Ma, D. Y., Upregulation of salivary α2 macroglobulin in patients with type 2 diabetes mellitus, vol. 14, pp. 2268-2274, 2015.

We investigated the expression of salivary α2-macroglobulin (α2-MG) in patients with type 2 diabetes mellitus (T2DM) to investigate its value for predicting damage to the salivary glands. A total of 116 patients with T2DM and 60 patients with impaired fasting glucose (IFG) were included in this study. Sixty health volunteers were enrolled as a control group. Unstimulated saliva was collected at 8 a.m. prior to breakfast. Expression of α2-MG was determined using an enzyme-linked immunosorbent assay.

Subscribe to α2-MG